

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 4.70422399 |
| 2 | positive regulation of mast cell activation (GO:0033005) | 4.30386840 |
| 3 | positive regulation of mast cell degranulation (GO:0043306) | 4.00248082 |
| 4 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.00248082 |
| 5 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.99803867 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.97600961 |
| 7 | regulation of mast cell degranulation (GO:0043304) | 3.91259123 |
| 8 | negative regulation of interleukin-12 production (GO:0032695) | 3.88924577 |
| 9 | glycosphingolipid catabolic process (GO:0046479) | 3.80203380 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.73866482 |
| 11 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.68117416 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 3.64062113 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 3.64062113 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.64062113 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.64062113 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.64062113 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 3.64062113 |
| 18 | positive regulation of leukocyte degranulation (GO:0043302) | 3.63377454 |
| 19 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.62929950 |
| 20 | regulation of mast cell activation (GO:0033003) | 3.59359272 |
| 21 | neutrophil activation (GO:0042119) | 3.56465163 |
| 22 | granulocyte activation (GO:0036230) | 3.54497617 |
| 23 | detection of other organism (GO:0098543) | 3.53299759 |
| 24 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.47754322 |
| 25 | cysteine metabolic process (GO:0006534) | 3.47448385 |
| 26 | cellular extravasation (GO:0045123) | 3.47133471 |
| 27 | glycolipid catabolic process (GO:0019377) | 3.47051554 |
| 28 | regulation of leukocyte degranulation (GO:0043300) | 3.42762007 |
| 29 | detection of molecule of bacterial origin (GO:0032490) | 3.38919162 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 3.38887354 |
| 31 | myeloid cell activation involved in immune response (GO:0002275) | 3.38012044 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.36575890 |
| 33 | protein carboxylation (GO:0018214) | 3.36575890 |
| 34 | oligosaccharide catabolic process (GO:0009313) | 3.35456307 |
| 35 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.35262904 |
| 36 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.30964178 |
| 37 | L-phenylalanine metabolic process (GO:0006558) | 3.30964178 |
| 38 | positive regulation of interferon-alpha production (GO:0032727) | 3.29541861 |
| 39 | urate metabolic process (GO:0046415) | 3.28399640 |
| 40 | low-density lipoprotein particle clearance (GO:0034383) | 3.27960992 |
| 41 | glyoxylate metabolic process (GO:0046487) | 3.23065988 |
| 42 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.20301113 |
| 43 | L-phenylalanine catabolic process (GO:0006559) | 3.19203378 |
| 44 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.19203378 |
| 45 | microglial cell activation (GO:0001774) | 3.17244373 |
| 46 | detection of external biotic stimulus (GO:0098581) | 3.17089867 |
| 47 | detection of bacterium (GO:0016045) | 3.15335476 |
| 48 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.12424860 |
| 49 | plasma lipoprotein particle clearance (GO:0034381) | 3.12336948 |
| 50 | regulation of platelet activation (GO:0010543) | 3.11591649 |
| 51 | B cell mediated immunity (GO:0019724) | 3.11141690 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.10283514 |
| 53 | glycine metabolic process (GO:0006544) | 3.09922233 |
| 54 | regulation of interferon-alpha production (GO:0032647) | 3.09918079 |
| 55 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.09457297 |
| 56 | aromatic amino acid family catabolic process (GO:0009074) | 3.08078844 |
| 57 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06364773 |
| 58 | mature B cell differentiation involved in immune response (GO:0002313) | 3.06164043 |
| 59 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.04606137 |
| 60 | alpha-linolenic acid metabolic process (GO:0036109) | 3.03963224 |
| 61 | homocysteine metabolic process (GO:0050667) | 3.03930901 |
| 62 | regulation of cholesterol storage (GO:0010885) | 3.03268157 |
| 63 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.01345620 |
| 64 | negative regulation of interleukin-17 production (GO:0032700) | 3.01131064 |
| 65 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.00983367 |
| 66 | ceramide catabolic process (GO:0046514) | 3.00947934 |
| 67 | serine family amino acid catabolic process (GO:0009071) | 2.99993357 |
| 68 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.98899981 |
| 69 | macrophage activation (GO:0042116) | 2.98276813 |
| 70 | urea cycle (GO:0000050) | 2.97424875 |
| 71 | urea metabolic process (GO:0019627) | 2.97424875 |
| 72 | folic acid metabolic process (GO:0046655) | 2.95124971 |
| 73 | lysine catabolic process (GO:0006554) | 2.94371642 |
| 74 | lysine metabolic process (GO:0006553) | 2.94371642 |
| 75 | serine family amino acid biosynthetic process (GO:0009070) | 2.94256571 |
| 76 | indole-containing compound catabolic process (GO:0042436) | 2.93859228 |
| 77 | indolalkylamine catabolic process (GO:0046218) | 2.93859228 |
| 78 | tryptophan catabolic process (GO:0006569) | 2.93859228 |
| 79 | negative regulation of fibrinolysis (GO:0051918) | 2.93851775 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 2.93379545 |
| 81 | tryptophan metabolic process (GO:0006568) | 2.92473260 |
| 82 | peptide catabolic process (GO:0043171) | 2.90983925 |
| 83 | phagocytosis, engulfment (GO:0006911) | 2.90764376 |
| 84 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90385319 |
| 85 | pinocytosis (GO:0006907) | 2.89977836 |
| 86 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.89522055 |
| 87 | lipoxygenase pathway (GO:0019372) | 2.89491214 |
| 88 | kynurenine metabolic process (GO:0070189) | 2.88726088 |
| 89 | positive regulation of antigen processing and presentation (GO:0002579) | 2.88220084 |
| 90 | regulation of hypersensitivity (GO:0002883) | 2.88151587 |
| 91 | amino-acid betaine metabolic process (GO:0006577) | 2.87955624 |
| 92 | folic acid transport (GO:0015884) | 2.85982386 |
| 93 | positive regulation of B cell differentiation (GO:0045579) | 2.85790711 |
| 94 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.84242650 |
| 95 | regulation of protein activation cascade (GO:2000257) | 2.82336345 |
| 96 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.82139730 |
| 97 | negative regulation of cell killing (GO:0031342) | 2.82139730 |
| 98 | regulation of platelet aggregation (GO:0090330) | 2.80674007 |
| 99 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.80180965 |
| 100 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.80180965 |
| 101 | complement activation, alternative pathway (GO:0006957) | 2.79062333 |
| 102 | regulation of macrophage chemotaxis (GO:0010758) | 2.77135334 |
| 103 | amino sugar catabolic process (GO:0046348) | 2.76537271 |
| 104 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.76526479 |
| 105 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.76493233 |
| 106 | regulation of antigen processing and presentation (GO:0002577) | 2.76056842 |
| 107 | detection of biotic stimulus (GO:0009595) | 2.73899077 |
| 108 | bile acid biosynthetic process (GO:0006699) | 2.73764807 |
| 109 | regulation of complement activation (GO:0030449) | 2.73367764 |
| 110 | regulation of mononuclear cell migration (GO:0071675) | 2.73095103 |
| 111 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.69862935 |
| 112 | nitrogen cycle metabolic process (GO:0071941) | 2.69200371 |
| 113 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.68197309 |
| 114 | aldehyde catabolic process (GO:0046185) | 2.67407795 |
| 115 | cell adhesion mediated by integrin (GO:0033627) | 2.65810172 |
| 116 | regulation of macrophage cytokine production (GO:0010935) | 2.65678945 |
| 117 | drug transport (GO:0015893) | 2.65199569 |
| 118 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.63434428 |
| 119 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.62652859 |
| 120 | regulation of regulated secretory pathway (GO:1903305) | 2.62611762 |
| 121 | regulation of gamma-delta T cell activation (GO:0046643) | 2.62453560 |
| 122 | positive regulation of macrophage differentiation (GO:0045651) | 2.62182177 |
| 123 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.61452984 |
| 124 | response to muramyl dipeptide (GO:0032495) | 2.61096995 |
| 125 | positive regulation of type 2 immune response (GO:0002830) | 2.60900903 |
| 126 | fibrinolysis (GO:0042730) | 2.60794442 |
| 127 | thrombin receptor signaling pathway (GO:0070493) | 2.60578723 |
| 128 | immunoglobulin mediated immune response (GO:0016064) | 2.60450894 |
| 129 | apoptotic cell clearance (GO:0043277) | 2.59499057 |
| 130 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.59354888 |
| 131 | response to host immune response (GO:0052572) | 2.58870964 |
| 132 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.58870964 |
| 133 | leukocyte degranulation (GO:0043299) | 2.58737750 |
| 134 | positive regulation of regulated secretory pathway (GO:1903307) | 2.58623822 |
| 135 | regulation of monocyte chemotaxis (GO:0090025) | 2.58459979 |
| 136 | drug transmembrane transport (GO:0006855) | 2.57522876 |
| 137 | respiratory burst (GO:0045730) | 2.56851720 |
| 138 | regulation of fibrinolysis (GO:0051917) | 2.56667930 |
| 139 | T-helper 1 type immune response (GO:0042088) | 2.54515055 |
| 140 | positive regulation of macrophage cytokine production (GO:0060907) | 2.53749618 |
| 141 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.53728850 |
| 142 | barbed-end actin filament capping (GO:0051016) | 2.53281157 |
| 143 | cellular modified amino acid catabolic process (GO:0042219) | 2.52609155 |
| 144 | regulation of cholesterol homeostasis (GO:2000188) | 2.52024527 |
| 145 | negative regulation of cholesterol transport (GO:0032375) | 2.52014528 |
| 146 | negative regulation of sterol transport (GO:0032372) | 2.52014528 |
| 147 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.51758278 |
| 148 | high-density lipoprotein particle remodeling (GO:0034375) | 2.50103889 |
| 149 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.49965087 |
| 150 | positive regulation of interferon-beta production (GO:0032728) | 2.49581620 |
| 151 | myeloid leukocyte activation (GO:0002274) | 2.49088397 |
| 152 | macrophage activation involved in immune response (GO:0002281) | 2.48878794 |
| 153 | angiogenesis involved in wound healing (GO:0060055) | 2.47084026 |
| 154 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.46346685 |
| 155 | positive regulation of interleukin-6 production (GO:0032755) | 2.46123455 |
| 156 | regulation of interleukin-17 production (GO:0032660) | 2.46069445 |
| 157 | lipoprotein metabolic process (GO:0042157) | 2.45831443 |
| 158 | phospholipid efflux (GO:0033700) | 2.42788289 |
| 159 | response to thyroid hormone (GO:0097066) | 2.42745762 |
| 160 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.42709591 |
| 161 | aromatic amino acid family metabolic process (GO:0009072) | 2.41279988 |
| 162 | cellular glucuronidation (GO:0052695) | 2.40720795 |
| 163 | protein-lipid complex assembly (GO:0065005) | 2.39613873 |
| 164 | plasma lipoprotein particle assembly (GO:0034377) | 2.39224005 |
| 165 | positive regulation of hemostasis (GO:1900048) | 2.37548912 |
| 166 | positive regulation of blood coagulation (GO:0030194) | 2.37548912 |
| 167 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.37327809 |
| 168 | pentose-phosphate shunt (GO:0006098) | 2.36517475 |
| 169 | 4-hydroxyproline metabolic process (GO:0019471) | 2.35992308 |
| 170 | reverse cholesterol transport (GO:0043691) | 2.35479352 |
| 171 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.34550929 |
| 172 | positive regulation of coagulation (GO:0050820) | 2.33675832 |
| 173 | NADPH regeneration (GO:0006740) | 2.33512054 |
| 174 | glucuronate metabolic process (GO:0019585) | 2.33487573 |
| 175 | uronic acid metabolic process (GO:0006063) | 2.33487573 |
| 176 | bile acid metabolic process (GO:0008206) | 2.32622809 |
| 177 | valine metabolic process (GO:0006573) | 2.31715969 |
| 178 | neutrophil activation involved in immune response (GO:0002283) | 2.31394617 |
| 179 | phospholipid homeostasis (GO:0055091) | 2.30961736 |
| 180 | cellular response to interferon-alpha (GO:0035457) | 2.29315581 |
| 181 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.27880533 |
| 182 | carnitine metabolic process (GO:0009437) | 2.27808420 |
| 183 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.26221082 |
| 184 | sterol homeostasis (GO:0055092) | 2.24346554 |
| 185 | macromolecular complex remodeling (GO:0034367) | 2.23661686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.79351409 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.40674275 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.21959066 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.20220080 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.00683198 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.98836097 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.93660308 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.92325792 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.62190065 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.61965562 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.60796462 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.58587839 |
| 13 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.50347010 |
| 14 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.49702303 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.48220842 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.41707234 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.38494142 |
| 18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34037589 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.31968019 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.26528696 |
| 21 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.18836842 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.14731764 |
| 23 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.13428882 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11121951 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07207612 |
| 26 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.04022853 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00584267 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.99510750 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.95566106 |
| 30 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.95254993 |
| 31 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.94312656 |
| 32 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.91286166 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.80904995 |
| 34 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.79572550 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78240882 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76200041 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75918444 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73993857 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.72122187 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71841003 |
| 41 | GATA1_19941826_ChIP-Seq_K562_Human | 1.71276952 |
| 42 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.69461365 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68989070 |
| 44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.67975422 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67010721 |
| 46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.66594695 |
| 47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64428884 |
| 48 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.60882396 |
| 49 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58298278 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56197199 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.55825213 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54756228 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.53499466 |
| 54 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.53075819 |
| 55 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.52978781 |
| 56 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.52768946 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.48771945 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.48137834 |
| 59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43912165 |
| 60 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43897841 |
| 61 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42935739 |
| 62 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.39751458 |
| 63 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.39603220 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38542739 |
| 65 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37681589 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.36277645 |
| 67 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.31189335 |
| 68 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.30803174 |
| 69 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30412313 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.26439342 |
| 71 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.24441587 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.21930083 |
| 73 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18868842 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18097585 |
| 75 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.17788625 |
| 76 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.17234605 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16831949 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16078984 |
| 79 | MYC_22102868_ChIP-Seq_BL_Human | 1.15900307 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13599786 |
| 81 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.13088606 |
| 82 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12992186 |
| 83 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11781069 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11633141 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.11134215 |
| 86 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09483633 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08733288 |
| 88 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.07887905 |
| 89 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06579934 |
| 90 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.04697548 |
| 91 | MAF_26560356_Chip-Seq_TH1_Human | 1.04664670 |
| 92 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04596957 |
| 93 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04298792 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03062888 |
| 95 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02647320 |
| 96 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02202348 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01877505 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01670154 |
| 99 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.01378955 |
| 100 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01275175 |
| 101 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.00527972 |
| 102 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99955975 |
| 103 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99848209 |
| 104 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.99457072 |
| 105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98286403 |
| 106 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98226659 |
| 107 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97953515 |
| 108 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.97297139 |
| 109 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95602593 |
| 110 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95441330 |
| 111 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95159762 |
| 112 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94834789 |
| 113 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94638879 |
| 114 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94542604 |
| 115 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94539688 |
| 116 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94520697 |
| 117 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.94281570 |
| 118 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.93380766 |
| 119 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.92772716 |
| 120 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92651628 |
| 121 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92577519 |
| 122 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.92376306 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92037735 |
| 124 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92037735 |
| 125 | MYB_26560356_Chip-Seq_TH1_Human | 0.91764368 |
| 126 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91698433 |
| 127 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91540354 |
| 128 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90739489 |
| 129 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.90627651 |
| 130 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90543013 |
| 131 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.90215620 |
| 132 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90165888 |
| 133 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90028054 |
| 134 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89450158 |
| 135 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89442301 |
| 136 | MYB_26560356_Chip-Seq_TH2_Human | 0.89226842 |
| 137 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88697197 |
| 138 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.88628854 |
| 139 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88435034 |
| 140 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.87657113 |
| 141 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.86613445 |
| 142 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86162804 |
| 143 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.85901770 |
| 144 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84917673 |
| 145 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82876353 |
| 146 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.80003852 |
| 147 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.80003852 |
| 148 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.79168179 |
| 149 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76275604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.84030321 |
| 2 | MP0005360_urolithiasis | 3.69463608 |
| 3 | MP0009840_abnormal_foam_cell | 3.44342353 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.03699654 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.87108147 |
| 6 | MP0005365_abnormal_bile_salt | 2.50576366 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.50195245 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.32734708 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.30403747 |
| 10 | MP0005671_abnormal_response_to | 2.19574829 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.15106879 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.13181708 |
| 13 | MP0008004_abnormal_stomach_pH | 2.05367923 |
| 14 | MP0003436_decreased_susceptibility_to | 1.99480295 |
| 15 | MP0003195_calcinosis | 1.92698346 |
| 16 | MP0003828_pulmonary_edema | 1.88993117 |
| 17 | MP0003172_abnormal_lysosome_physiology | 1.87680887 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 1.80659946 |
| 19 | MP0003252_abnormal_bile_duct | 1.69259655 |
| 20 | MP0010329_abnormal_lipoprotein_level | 1.66604626 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 1.65094395 |
| 22 | MP0005332_abnormal_amino_acid | 1.61686651 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.59707534 |
| 24 | MP0005083_abnormal_biliary_tract | 1.59428255 |
| 25 | MP0003186_abnormal_redox_activity | 1.58849539 |
| 26 | MP0006082_CNS_inflammation | 1.57042599 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.56690540 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.53094445 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.48411516 |
| 30 | MP0003303_peritoneal_inflammation | 1.46925730 |
| 31 | MP0002419_abnormal_innate_immunity | 1.46487773 |
| 32 | MP0004510_myositis | 1.44519177 |
| 33 | MP0000609_abnormal_liver_physiology | 1.43271524 |
| 34 | MP0010307_abnormal_tumor_latency | 1.43001847 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.37353603 |
| 36 | MP0005023_abnormal_wound_healing | 1.34674143 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.30558627 |
| 38 | MP0004947_skin_inflammation | 1.27968287 |
| 39 | MP0005164_abnormal_response_to | 1.27829362 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.25151120 |
| 41 | MP0008469_abnormal_protein_level | 1.24983660 |
| 42 | MP0000604_amyloidosis | 1.24588991 |
| 43 | MP0000716_abnormal_immune_system | 1.23897317 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.21748915 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.21668959 |
| 46 | MP0001666_abnormal_nutrient_absorption | 1.21650370 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.20577076 |
| 48 | MP0009785_altered_susceptibility_to | 1.19692165 |
| 49 | MP0003690_abnormal_glial_cell | 1.19608328 |
| 50 | MP0002398_abnormal_bone_marrow | 1.18559129 |
| 51 | MP0005025_abnormal_response_to | 1.17521822 |
| 52 | MP0002254_reproductive_system_inflammat | 1.16644726 |
| 53 | MP0005166_decreased_susceptibility_to | 1.16387261 |
| 54 | MP0004883_abnormal_blood_vessel | 1.15655485 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.15496324 |
| 56 | MP0005165_increased_susceptibility_to | 1.15242704 |
| 57 | MP0000598_abnormal_liver_morphology | 1.14486623 |
| 58 | MP0006054_spinal_hemorrhage | 1.14459989 |
| 59 | MP0001851_eye_inflammation | 1.11534758 |
| 60 | MP0008260_abnormal_autophagy | 1.09961932 |
| 61 | MP0000685_abnormal_immune_system | 1.08795320 |
| 62 | MP0005000_abnormal_immune_tolerance | 1.08699849 |
| 63 | MP0003693_abnormal_embryo_hatching | 1.08368357 |
| 64 | MP0001958_emphysema | 1.07612237 |
| 65 | MP0005275_abnormal_skin_tensile | 1.07439035 |
| 66 | MP0002136_abnormal_kidney_physiology | 1.07271557 |
| 67 | MP0000249_abnormal_blood_vessel | 1.07096051 |
| 68 | MP0003724_increased_susceptibility_to | 1.07053248 |
| 69 | MP0005310_abnormal_salivary_gland | 1.06127742 |
| 70 | MP0009764_decreased_sensitivity_to | 1.05238522 |
| 71 | MP0002429_abnormal_blood_cell | 1.05044277 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.04832390 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.04758352 |
| 74 | MP0000858_altered_metastatic_potential | 0.98759975 |
| 75 | MP0005076_abnormal_cell_differentiation | 0.98662327 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 0.97860946 |
| 77 | MP0001853_heart_inflammation | 0.97828696 |
| 78 | MP0005390_skeleton_phenotype | 0.96574779 |
| 79 | MP0002148_abnormal_hypersensitivity_rea | 0.96516713 |
| 80 | MP0002722_abnormal_immune_system | 0.96423771 |
| 81 | MP0001756_abnormal_urination | 0.96007054 |
| 82 | MP0000343_altered_response_to | 0.95492668 |
| 83 | MP0005408_hypopigmentation | 0.94647149 |
| 84 | MP0003448_altered_tumor_morphology | 0.94510655 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 0.93558628 |
| 86 | MP0001542_abnormal_bone_strength | 0.92357720 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.91340487 |
| 88 | MP0003279_aneurysm | 0.91204327 |
| 89 | MP0005397_hematopoietic_system_phenotyp | 0.91109318 |
| 90 | MP0001545_abnormal_hematopoietic_system | 0.91109318 |
| 91 | MP0009763_increased_sensitivity_to | 0.90572313 |
| 92 | MP0009278_abnormal_bone_marrow | 0.90417167 |
| 93 | MP0003795_abnormal_bone_structure | 0.90247821 |
| 94 | MP0000569_abnormal_digit_pigmentation | 0.90040379 |
| 95 | MP0001800_abnormal_humoral_immune | 0.89801960 |
| 96 | MP0005451_abnormal_body_composition | 0.88415688 |
| 97 | MP0002166_altered_tumor_susceptibility | 0.87952258 |
| 98 | MP0002723_abnormal_immune_serum | 0.87446777 |
| 99 | MP0002060_abnormal_skin_morphology | 0.86150136 |
| 100 | MP0003763_abnormal_thymus_physiology | 0.85283964 |
| 101 | MP0002132_abnormal_respiratory_system | 0.84836298 |
| 102 | MP0005387_immune_system_phenotype | 0.84535309 |
| 103 | MP0001790_abnormal_immune_system | 0.84535309 |
| 104 | MP0002877_abnormal_melanocyte_morpholog | 0.84467683 |
| 105 | MP0002396_abnormal_hematopoietic_system | 0.84455816 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 0.84356271 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82745010 |
| 108 | MP0001663_abnormal_digestive_system | 0.82096745 |
| 109 | MP0004808_abnormal_hematopoietic_stem | 0.81831560 |
| 110 | MP0000371_diluted_coat_color | 0.80690984 |
| 111 | MP0001915_intracranial_hemorrhage | 0.80247470 |
| 112 | MP0000490_abnormal_crypts_of | 0.80022081 |
| 113 | MP0000465_gastrointestinal_hemorrhage | 0.79501514 |
| 114 | MP0003866_abnormal_defecation | 0.79470943 |
| 115 | MP0002405_respiratory_system_inflammati | 0.78120928 |
| 116 | MP0009333_abnormal_splenocyte_physiolog | 0.77830687 |
| 117 | MP0009053_abnormal_anal_canal | 0.77716745 |
| 118 | MP0000689_abnormal_spleen_morphology | 0.77201040 |
| 119 | MP0002998_abnormal_bone_remodeling | 0.77157801 |
| 120 | MP0001819_abnormal_immune_cell | 0.76443373 |
| 121 | MP0002420_abnormal_adaptive_immunity | 0.75655803 |
| 122 | MP0002135_abnormal_kidney_morphology | 0.74818700 |
| 123 | MP0009384_cardiac_valve_regurgitation | 0.74790480 |
| 124 | MP0010155_abnormal_intestine_physiology | 0.74634406 |
| 125 | MP0005257_abnormal_intraocular_pressure | 0.74442815 |
| 126 | MP0004957_abnormal_blastocyst_morpholog | 0.74133694 |
| 127 | MP0001764_abnormal_homeostasis | 0.72272194 |
| 128 | MP0003091_abnormal_cell_migration | 0.72204250 |
| 129 | MP0001243_abnormal_dermal_layer | 0.71942299 |
| 130 | MP0003075_altered_response_to | 0.69179159 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.66349319 |
| 132 | MP0000920_abnormal_myelination | 0.63507540 |
| 133 | MP0008874_decreased_physiological_sensi | 0.63061796 |
| 134 | MP0002006_tumorigenesis | 0.61836385 |
| 135 | MP0010386_abnormal_urinary_bladder | 0.57780692 |
| 136 | MP0002332_abnormal_exercise_endurance | 0.54233974 |
| 137 | MP0005647_abnormal_sex_gland | 0.53228177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 4.43132149 |
| 2 | Prolonged bleeding time (HP:0003010) | 4.38816942 |
| 3 | Purpura (HP:0000979) | 4.38024884 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.15822186 |
| 5 | Xanthomatosis (HP:0000991) | 3.98258129 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 3.88164921 |
| 7 | Epistaxis (HP:0000421) | 3.76400412 |
| 8 | Deep venous thrombosis (HP:0002625) | 3.52800718 |
| 9 | Myocardial infarction (HP:0001658) | 3.46655492 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.42459299 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.41944236 |
| 12 | Spontaneous hematomas (HP:0007420) | 3.34509017 |
| 13 | Loss of speech (HP:0002371) | 3.34214521 |
| 14 | Complement deficiency (HP:0004431) | 3.31175579 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.28980347 |
| 16 | Abnormal platelet volume (HP:0011876) | 3.28406170 |
| 17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.25560289 |
| 18 | Increased mean platelet volume (HP:0011877) | 3.22204300 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.19151885 |
| 20 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.14124184 |
| 21 | Intrahepatic cholestasis (HP:0001406) | 3.13252422 |
| 22 | Menorrhagia (HP:0000132) | 3.04746877 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.04249215 |
| 24 | Obstructive lung disease (HP:0006536) | 3.04249215 |
| 25 | Glomerulonephritis (HP:0000099) | 3.02649303 |
| 26 | Mucopolysacchariduria (HP:0008155) | 3.01025170 |
| 27 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.01025170 |
| 28 | Abnormality of macrophages (HP:0004311) | 2.95717020 |
| 29 | Abnormality of complement system (HP:0005339) | 2.93073419 |
| 30 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.92443832 |
| 31 | Recurrent abscess formation (HP:0002722) | 2.89345581 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 2.89255671 |
| 33 | Hypobetalipoproteinemia (HP:0003563) | 2.89001084 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 2.86504137 |
| 35 | Hepatosplenomegaly (HP:0001433) | 2.84833259 |
| 36 | Stomatitis (HP:0010280) | 2.83122030 |
| 37 | Amyloidosis (HP:0011034) | 2.80182357 |
| 38 | Recurrent bacterial skin infections (HP:0005406) | 2.79882102 |
| 39 | Eczematoid dermatitis (HP:0000976) | 2.78699786 |
| 40 | Orchitis (HP:0100796) | 2.78690532 |
| 41 | Recurrent skin infections (HP:0001581) | 2.75526677 |
| 42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.75192107 |
| 43 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.75192107 |
| 44 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.75192107 |
| 45 | Joint hemorrhage (HP:0005261) | 2.73726858 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.66617159 |
| 47 | Impaired platelet aggregation (HP:0003540) | 2.64849755 |
| 48 | Abnormal platelet function (HP:0011869) | 2.64849755 |
| 49 | Abnormality of the common coagulation pathway (HP:0010990) | 2.62990639 |
| 50 | Osteolytic defects of the hand bones (HP:0009699) | 2.61456479 |
| 51 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.61456479 |
| 52 | Esophageal varix (HP:0002040) | 2.57977535 |
| 53 | Abnormality of glycolipid metabolism (HP:0010969) | 2.57181070 |
| 54 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.57181070 |
| 55 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.57181070 |
| 56 | Hypolipoproteinemia (HP:0010981) | 2.56425013 |
| 57 | Hyperglycinuria (HP:0003108) | 2.55388360 |
| 58 | Recurrent fungal infections (HP:0002841) | 2.54631377 |
| 59 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.53725717 |
| 60 | Axonal loss (HP:0003447) | 2.51570255 |
| 61 | Hypoalphalipoproteinemia (HP:0003233) | 2.50043971 |
| 62 | Retrobulbar optic neuritis (HP:0100654) | 2.47816314 |
| 63 | Optic neuritis (HP:0100653) | 2.47816314 |
| 64 | Hypoglycemic coma (HP:0001325) | 2.46895929 |
| 65 | Hyperammonemia (HP:0001987) | 2.46817767 |
| 66 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.44430461 |
| 67 | Prolonged partial thromboplastin time (HP:0003645) | 2.44010838 |
| 68 | Peritonitis (HP:0002586) | 2.43703662 |
| 69 | Gingivitis (HP:0000230) | 2.43578142 |
| 70 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.40887018 |
| 71 | Nausea (HP:0002018) | 2.39362607 |
| 72 | Abnormality of proline metabolism (HP:0010907) | 2.39212133 |
| 73 | Hydroxyprolinuria (HP:0003080) | 2.39212133 |
| 74 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.38461360 |
| 75 | Abnormality of glycine metabolism (HP:0010895) | 2.38461360 |
| 76 | Hematochezia (HP:0002573) | 2.38032865 |
| 77 | Spastic diplegia (HP:0001264) | 2.35443537 |
| 78 | Hyperglycinemia (HP:0002154) | 2.33548072 |
| 79 | Hypercholesterolemia (HP:0003124) | 2.32924046 |
| 80 | Cervical subluxation (HP:0003308) | 2.32499328 |
| 81 | Premature rupture of membranes (HP:0001788) | 2.32011202 |
| 82 | Arterial thrombosis (HP:0004420) | 2.31406783 |
| 83 | Pustule (HP:0200039) | 2.28830154 |
| 84 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.28470329 |
| 85 | Nephritis (HP:0000123) | 2.26558102 |
| 86 | Vertebral compression fractures (HP:0002953) | 2.25977094 |
| 87 | Progressive neurologic deterioration (HP:0002344) | 2.23643529 |
| 88 | Pulmonary infiltrates (HP:0002113) | 2.21684507 |
| 89 | Abnormality of nucleobase metabolism (HP:0010932) | 2.21502360 |
| 90 | Urticaria (HP:0001025) | 2.20143697 |
| 91 | Keratoconjunctivitis sicca (HP:0001097) | 2.19428531 |
| 92 | Basal ganglia calcification (HP:0002135) | 2.19010631 |
| 93 | Chest pain (HP:0100749) | 2.19005914 |
| 94 | Spondylolisthesis (HP:0003302) | 2.18317416 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 2.18018375 |
| 96 | Disinhibition (HP:0000734) | 2.17586708 |
| 97 | Recurrent cutaneous fungal infections (HP:0011370) | 2.16573816 |
| 98 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.16573816 |
| 99 | Meningitis (HP:0001287) | 2.14116293 |
| 100 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13983556 |
| 101 | Recurrent viral infections (HP:0004429) | 2.13376090 |
| 102 | Conjunctival telangiectasia (HP:0000524) | 2.12330720 |
| 103 | Fat malabsorption (HP:0002630) | 2.12198843 |
| 104 | Thrombocytosis (HP:0001894) | 2.11682454 |
| 105 | Protrusio acetabuli (HP:0003179) | 2.08043593 |
| 106 | Mutism (HP:0002300) | 2.07260883 |
| 107 | Hemoptysis (HP:0002105) | 2.06589536 |
| 108 | Abnormality of the prostate (HP:0008775) | 2.05432474 |
| 109 | Vasculitis (HP:0002633) | 2.02309437 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 2.02152714 |
| 111 | Hepatocellular carcinoma (HP:0001402) | 2.01251257 |
| 112 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.01210863 |
| 113 | Autoimmune thrombocytopenia (HP:0001973) | 2.00736630 |
| 114 | Cardiovascular calcification (HP:0011915) | 2.00646420 |
| 115 | Cellulitis (HP:0100658) | 2.00567131 |
| 116 | Interstitial pulmonary disease (HP:0006530) | 1.99919251 |
| 117 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.99671155 |
| 118 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99407376 |
| 119 | Pathologic fracture (HP:0002756) | 1.99224565 |
| 120 | Tetraparesis (HP:0002273) | 1.98773683 |
| 121 | Vascular calcification (HP:0004934) | 1.98334119 |
| 122 | Keratoconjunctivitis (HP:0001096) | 1.97855084 |
| 123 | Mucosal telangiectasiae (HP:0100579) | 1.94240943 |
| 124 | Polycythemia (HP:0001901) | 1.93647622 |
| 125 | Increased serum ferritin (HP:0003281) | 1.93167699 |
| 126 | Proximal tubulopathy (HP:0000114) | 1.92385239 |
| 127 | T lymphocytopenia (HP:0005403) | 1.91700468 |
| 128 | Mitral stenosis (HP:0001718) | 1.91079402 |
| 129 | Bruising susceptibility (HP:0000978) | 1.90709074 |
| 130 | Gout (HP:0001997) | 1.90283652 |
| 131 | Ketosis (HP:0001946) | 1.89925761 |
| 132 | Neurofibrillary tangles (HP:0002185) | 1.89800856 |
| 133 | Pulmonary embolism (HP:0002204) | 1.88272889 |
| 134 | Gingival bleeding (HP:0000225) | 1.87524468 |
| 135 | Epidermoid cyst (HP:0200040) | 1.86444471 |
| 136 | Skin nodule (HP:0200036) | 1.86418727 |
| 137 | Abnormal cartilage morphology (HP:0002763) | 1.85035389 |
| 138 | Upper motor neuron abnormality (HP:0002127) | 1.84688785 |
| 139 | Generalized aminoaciduria (HP:0002909) | 1.82956322 |
| 140 | Asymmetric septal hypertrophy (HP:0001670) | 1.81783111 |
| 141 | Leukocytosis (HP:0001974) | 1.81673361 |
| 142 | Thrombophlebitis (HP:0004418) | 1.81130339 |
| 143 | Vertigo (HP:0002321) | 1.81064291 |
| 144 | Osteomyelitis (HP:0002754) | 1.80837918 |
| 145 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.80157787 |
| 146 | Episodic fever (HP:0001954) | 1.79288174 |
| 147 | Protuberant abdomen (HP:0001538) | 1.78736718 |
| 148 | Abnormality of T cell number (HP:0011839) | 1.78591652 |
| 149 | Amaurosis fugax (HP:0100576) | 1.78588194 |
| 150 | Polyneuropathy (HP:0001271) | 1.78231125 |
| 151 | J-shaped sella turcica (HP:0002680) | 1.77874735 |
| 152 | Encephalitis (HP:0002383) | 1.77508261 |
| 153 | Global brain atrophy (HP:0002283) | 1.76742002 |
| 154 | Thoracic kyphosis (HP:0002942) | 1.75746963 |
| 155 | Myositis (HP:0100614) | 1.75680415 |
| 156 | Steatorrhea (HP:0002570) | 1.75520162 |
| 157 | Autoimmune hemolytic anemia (HP:0001890) | 1.75217555 |
| 158 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.71971107 |
| 159 | Abnormality of methionine metabolism (HP:0010901) | 1.71827778 |
| 160 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.71643892 |
| 161 | Joint swelling (HP:0001386) | 1.71506727 |
| 162 | Hypergammaglobulinemia (HP:0010702) | 1.70796570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.02002857 |
| 2 | ERN1 | 3.25784794 |
| 3 | SCYL2 | 2.73395862 |
| 4 | TRIB3 | 2.41061710 |
| 5 | TYK2 | 2.37845379 |
| 6 | BMPR2 | 2.37700914 |
| 7 | BCKDK | 2.25442748 |
| 8 | TBK1 | 2.24187865 |
| 9 | PKN2 | 2.14680743 |
| 10 | NME2 | 2.11638451 |
| 11 | TGFBR2 | 2.07413495 |
| 12 | BLK | 2.04103003 |
| 13 | NEK9 | 1.96254533 |
| 14 | FES | 1.92607466 |
| 15 | SYK | 1.91341628 |
| 16 | STK10 | 1.89860931 |
| 17 | TEC | 1.79718532 |
| 18 | GRK7 | 1.78878602 |
| 19 | MAP3K3 | 1.76075844 |
| 20 | LRRK2 | 1.73016143 |
| 21 | EPHA2 | 1.72392165 |
| 22 | FGFR4 | 1.64532306 |
| 23 | KIT | 1.60726118 |
| 24 | PIM2 | 1.56502489 |
| 25 | MAP2K3 | 1.54566060 |
| 26 | FGR | 1.54437843 |
| 27 | PAK4 | 1.54063300 |
| 28 | MAP3K14 | 1.46029626 |
| 29 | RPS6KA4 | 1.45063815 |
| 30 | IRAK3 | 1.43429340 |
| 31 | MST1R | 1.43235722 |
| 32 | PRPF4B | 1.38245778 |
| 33 | MYLK | 1.36974735 |
| 34 | PBK | 1.36708069 |
| 35 | CAMKK2 | 1.35444346 |
| 36 | WEE1 | 1.33697788 |
| 37 | FLT3 | 1.33590549 |
| 38 | CSF1R | 1.32301985 |
| 39 | TAOK2 | 1.29441074 |
| 40 | SIK1 | 1.29003067 |
| 41 | IKBKB | 1.27799500 |
| 42 | MAP4K1 | 1.27753660 |
| 43 | ZAP70 | 1.26012444 |
| 44 | TTN | 1.25086518 |
| 45 | EIF2AK1 | 1.24199226 |
| 46 | PTK6 | 1.22749719 |
| 47 | JAK3 | 1.20505986 |
| 48 | MAP3K13 | 1.19658849 |
| 49 | MAP3K8 | 1.16129429 |
| 50 | KDR | 1.14754039 |
| 51 | TXK | 1.12027080 |
| 52 | PIM1 | 1.09616362 |
| 53 | NEK2 | 1.09519973 |
| 54 | CDK6 | 1.09320751 |
| 55 | IRAK4 | 1.09190612 |
| 56 | RIPK1 | 1.08041329 |
| 57 | JAK1 | 1.07443174 |
| 58 | ABL2 | 1.06906183 |
| 59 | STK3 | 1.06526226 |
| 60 | EIF2AK3 | 1.05751394 |
| 61 | MAP3K11 | 1.01610642 |
| 62 | LATS1 | 0.99084654 |
| 63 | FRK | 0.98902735 |
| 64 | TAOK3 | 0.95077209 |
| 65 | CSK | 0.94848206 |
| 66 | CAMK1D | 0.94608842 |
| 67 | LCK | 0.91979608 |
| 68 | MST4 | 0.90998472 |
| 69 | IKBKE | 0.90114185 |
| 70 | BUB1 | 0.90110633 |
| 71 | TESK2 | 0.89285577 |
| 72 | MAP3K6 | 0.88596580 |
| 73 | MAP3K1 | 0.87630594 |
| 74 | ITK | 0.86775808 |
| 75 | TAOK1 | 0.84882969 |
| 76 | CHUK | 0.83647920 |
| 77 | BRSK2 | 0.83337562 |
| 78 | NEK1 | 0.83221912 |
| 79 | STK4 | 0.82168439 |
| 80 | PDPK1 | 0.82096122 |
| 81 | TNK2 | 0.80804783 |
| 82 | DDR2 | 0.77856355 |
| 83 | MOS | 0.77587340 |
| 84 | JAK2 | 0.76917873 |
| 85 | PTK2B | 0.76025130 |
| 86 | CDK4 | 0.75870928 |
| 87 | MET | 0.74929050 |
| 88 | TGFBR1 | 0.74702048 |
| 89 | MATK | 0.74392209 |
| 90 | IRAK1 | 0.73435424 |
| 91 | PDGFRA | 0.72984190 |
| 92 | PDK1 | 0.72596120 |
| 93 | EEF2K | 0.72348471 |
| 94 | BMX | 0.71344270 |
| 95 | CDC42BPA | 0.70791658 |
| 96 | IRAK2 | 0.70301518 |
| 97 | ACVR1B | 0.69849508 |
| 98 | EPHB1 | 0.69529920 |
| 99 | MAP3K10 | 0.69107746 |
| 100 | TTK | 0.69006248 |
| 101 | PDK2 | 0.68090863 |
| 102 | GRK6 | 0.68036447 |
| 103 | TRPM7 | 0.67903486 |
| 104 | ADRBK2 | 0.67480756 |
| 105 | BTK | 0.65858692 |
| 106 | MAP2K2 | 0.63818292 |
| 107 | PAK2 | 0.62761422 |
| 108 | MAP3K5 | 0.61072036 |
| 109 | DYRK1B | 0.60621028 |
| 110 | MAPK12 | 0.60485195 |
| 111 | MAPKAPK3 | 0.58525863 |
| 112 | RPS6KB2 | 0.57495450 |
| 113 | PTK2 | 0.56088638 |
| 114 | LYN | 0.55203522 |
| 115 | MAPK11 | 0.54538988 |
| 116 | MARK3 | 0.54261827 |
| 117 | MAPK7 | 0.54166839 |
| 118 | HCK | 0.54047068 |
| 119 | ERBB4 | 0.52709544 |
| 120 | EGFR | 0.52676913 |
| 121 | NUAK1 | 0.52235998 |
| 122 | FGFR3 | 0.51832796 |
| 123 | ARAF | 0.50776037 |
| 124 | TESK1 | 0.49667583 |
| 125 | PIK3CG | 0.49238394 |
| 126 | MTOR | 0.48392677 |
| 127 | AURKB | 0.48038157 |
| 128 | CDK12 | 0.48002137 |
| 129 | YES1 | 0.47612277 |
| 130 | FER | 0.45948504 |
| 131 | EPHA3 | 0.45705538 |
| 132 | ABL1 | 0.45695638 |
| 133 | FYN | 0.45216261 |
| 134 | DYRK3 | 0.44744510 |
| 135 | MAP3K12 | 0.44254052 |
| 136 | MAP3K2 | 0.43943291 |
| 137 | MAPKAPK2 | 0.43091954 |
| 138 | PRKD1 | 0.42125492 |
| 139 | MAPK4 | 0.40929913 |
| 140 | HIPK2 | 0.40853973 |
| 141 | SIK3 | 0.39492772 |
| 142 | RPS6KL1 | 0.39406577 |
| 143 | RPS6KC1 | 0.39406577 |
| 144 | PRKCD | 0.38917000 |
| 145 | PDGFRB | 0.36414471 |
| 146 | DAPK3 | 0.36382861 |
| 147 | RPS6KA2 | 0.36233526 |
| 148 | GRK5 | 0.35874671 |
| 149 | IGF1R | 0.34960578 |
| 150 | ILK | 0.33813207 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 2.96542211 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.79984055 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.70802541 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.70670340 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.58527312 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.50084896 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.34949208 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.32998154 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.28883164 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.24640844 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.22784301 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.16769444 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.00151211 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.96995310 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.92177469 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.91802925 |
| 17 | Lysosome_Homo sapiens_hsa04142 | 1.89344386 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.86385385 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.85498720 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.82278357 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.81961104 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.80404017 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.76190347 |
| 24 | Platelet activation_Homo sapiens_hsa04611 | 1.74721132 |
| 25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.68283642 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.67093677 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65824097 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.65591567 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.58835713 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52500041 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.49236906 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.48905494 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44067152 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42857937 |
| 35 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.39250326 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.30791462 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.27517815 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25241257 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.24735598 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24189872 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.23774411 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.23536299 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22041367 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.21246774 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21102513 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.19752445 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18757066 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17422246 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.17249767 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15066395 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14023980 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10997695 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.10243816 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.08443782 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.07327037 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.03892363 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03517950 |
| 58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.02776273 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01969315 |
| 60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.99220912 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98117251 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97765732 |
| 63 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.96492838 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.94844146 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.94616269 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93775323 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93314195 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.92880292 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91367655 |
| 70 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91226806 |
| 71 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.90345941 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.90004989 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89508147 |
| 74 | Proteasome_Homo sapiens_hsa03050 | 0.88715455 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.87423177 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87006762 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.86734735 |
| 78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83883135 |
| 79 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83433468 |
| 80 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.83378877 |
| 81 | Malaria_Homo sapiens_hsa05144 | 0.80494411 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79882571 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.77565869 |
| 84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76794389 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75502617 |
| 86 | Tuberculosis_Homo sapiens_hsa05152 | 0.74281688 |
| 87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73678708 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.72778480 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.72760713 |
| 90 | Bile secretion_Homo sapiens_hsa04976 | 0.72073036 |
| 91 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.71906970 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70310975 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68950010 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68792604 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68780904 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.68697899 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.68200624 |
| 98 | Hepatitis B_Homo sapiens_hsa05161 | 0.66917088 |
| 99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66669627 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66636696 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65275218 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64656604 |
| 103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.63944736 |
| 104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.62264667 |
| 105 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60234552 |
| 106 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59688700 |
| 107 | DNA replication_Homo sapiens_hsa03030 | 0.59411933 |
| 108 | Shigellosis_Homo sapiens_hsa05131 | 0.59403191 |
| 109 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58638039 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58497945 |
| 111 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57910358 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.57683870 |
| 113 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57646803 |
| 114 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57240074 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55747989 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55360739 |
| 117 | Measles_Homo sapiens_hsa05162 | 0.55232367 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55203243 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.54650417 |
| 120 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.54537965 |
| 121 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.54284253 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53152633 |
| 123 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51979815 |
| 124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51704758 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.51406359 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | 0.50651153 |
| 127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50018751 |
| 128 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.48894871 |
| 129 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48777585 |
| 130 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48534566 |
| 131 | Influenza A_Homo sapiens_hsa05164 | 0.48515367 |
| 132 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48464030 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47021522 |
| 134 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46198892 |
| 135 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44411413 |
| 136 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.44104043 |
| 137 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43937214 |
| 138 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42940458 |
| 139 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42534416 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41578631 |
| 141 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41135618 |
| 142 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.39055188 |
| 143 | Hepatitis C_Homo sapiens_hsa05160 | 0.38585757 |
| 144 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37471470 |
| 145 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33381431 |
| 146 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33342630 |
| 147 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33112882 |
| 148 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33110045 |
| 149 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32584283 |
| 150 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32448849 |
| 151 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31792007 |
| 152 | Prion diseases_Homo sapiens_hsa05020 | 0.28563007 |
| 153 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28461215 |
| 154 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28386247 |
| 155 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25279946 |
| 156 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23937164 |
| 157 | Mineral absorption_Homo sapiens_hsa04978 | 0.21800108 |

